Last reviewed · How we verify
NCT06060197
MCT8 Deficiency Caregiver Study
trial in Monocarboxylate Transporter 8 (MCT8) Deficiency in 21 participants. Completed in 12 April 2024.
12 April 2024
Quick facts
| Lead sponsor | Rare Thyroid Therapeutics International AB |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 21 |
| Start date | 23 August 2022 |
| Primary completion | 12 April 2024 |
| Estimated completion | 12 April 2024 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Monocarboxylate Transporter 8 (MCT8) Deficiency — all drugs for Monocarboxylate Transporter 8 (MCT8) Deficiency →
- Allan-Herndon-Dudley Syndrome — all drugs for Allan-Herndon-Dudley Syndrome →
Sponsor
Rare Thyroid Therapeutics International AB
Who can join
18 and older, any sex, with Monocarboxylate Transporter 8 (MCT8) Deficiency or Allan-Herndon-Dudley Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Caregivers face many responsibilities outside of their role as a friend or parent, which can lead to emotional, financial, social, and professional challenges. To better understand the impact of MCT8 deficiency on caregivers, Egetis Therapeutics are conducting an online survey for adult caregivers of persons living with the MCT8 deficiency.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06060197
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Rare Thyroid Therapeutics International AB trials
Trials by the same sponsor.
- NCT05579327 — Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency) · Phase 3 · completed
- NCT02396459 — Triac Trial II in MCT8 Deficiency Patients · Phase 2 · active not recruiting
- NCT05911399 — Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency · available
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06060197 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rare Thyroid Therapeutics International AB
- Last refreshed: 25 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06060197.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing